tirzepatide news update Compounded versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said Here’s my tirzepatide update! Big

PubMed Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic, T., Bilic, Z., Sjekavica, I., Djuzel, A.R., Knezevic, M., Sever, A.Z., Lojo, N., Kokot, A., Sever, M., Drmic, D., Seiwerth, S., Sikiric, P

If kidney function declines, expect a slower decline and plan to follow up with labs or dose checks sooner

Symptoms of low calcium include numbness or tingling in fingers and toes, muscle aches , cramps, and in severe cases, confusion or memory problems

Cloudiness or persistent particles are warning signs see the troubleshooting section

Market Restraint High Cost of GLP-1-Based Weight Loss Medications The high cost of GLP-1 receptor agonists for obesity management is a major restraint limiting their widespread adoption